spacer
home > pmps > winter 2001 > biopharma process systems from a land flowing with milk and wine - the demand for high-tech biomanufacturing equipment
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Biopharma Process Systems from a Land Flowing With Milk and Wine - The Demand For High-Tech Biomanufacturing Equipment

Q Denis, tell me how BIOLAFITTE & MORITZ evolved?A My father founded PIERRE GUERIN in 1949 at Mauzé-sur-le-Mignon, in the heart of the first milk- and cheese-producing region in France. It was a family business where we designed and produced stainless steel processvessels, pumps, valves, agitation and mixing systems for the food processing industry (such as milk desserts, fresh products, ice creams, yoghurts, pressed cheeses and wine vintages). Then it transferred its knowledge of hygiene and processing vats for the food industry to the pharmaceutical and cosmetic industries and more recently to the biotechnology industry.

In November 1998, PIERRE GUERIN S.A. acquired the company BIOLAFITTE,

consolidating its own knowledge and reputation within the biotechnology industry. Recently created, the division BIOLAFITTE & MORITZ, became a leader in the biopharmaceutical sector.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
As a predicted shortfall in production capacity for proteins (for example, monoclonal antibodies), compels the biopharmaceutical sector to consider its supply strategy for the next five years, the manufacturers of process equipment are at the front line ready to meet the demand for more sophisticated vessels and process control equipment. A leading supplier of biopharmaceutical process systems is BIOLAFITTE & MORITZ, based in Mauzй, France. Dr Patricia Lobo, Editor of PMPS, visits BIOLAFITTE & MORITZ to meet Denis Guerin, Senior Project Engineer, Daniel Blanchi, Director and Doru Felezeu, International Director of the company.
spacer
Denis Guerin
spacer
spacer
spacer
Daniel Blanchi
spacer
spacer
spacer
Doru Felezeu
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

High Throughput Analytics Herald a Paradigm Shift in the Development of Biopharmaceuticals

Heilbronn/Dortmund August 2019: Biopharmaceuticals have revolutionized therapies of various diseases. In particular with regard to chronical and/or severe clinical conditions like multiple sclerosis, rheumatoid arthritis or cancer they are considered the future of treatment. Also economically biological drugs are on their way up: The global biopharmaceuticals market is anticipated to reach about 400 billion USD by 2025. Which strategic alignment will help best to fill a successful pipeline?
More info >>

White Papers

Changing Structural Landscape for Comparator Drug Supply

ADAllen Pharma

TransCelerate Biopharma is focused on advancing innovation in R&D, identifying and solving common R&D challenges and further improving patient safety, with the goal of delivering more high quality medicines to patients. In 2013, they announced its Clinical Trial Comparator Network initiative to show a mutual commitment to offer secure and rapid supply of comparator drug products. The aim of this article is to unpack the section on 'Comparator Drugs' and analyse the rationale for attempting to achieve their objectives.
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India forhigh quality, low   cost pharma solutions, CPhI & P-MEC Indiais the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India’s pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement